Results 21 to 30 of about 11,374,515 (391)

Dynamics of multi-stage infections on networks [PDF]

, 2015
This paper investigates the dynamics of infectious diseases with a nonexponentially distributed infectious period. This is achieved by considering a multistage infection model on networks. Using pairwise approximation with a standard closure, a number of
AJ Black, AL Lloyd, AL Lloyd, CA Donnelly, CT Bauch, D Anderson, DR Cox, DT Gillespie, E Kenah, EH Kaplan, G Chowell, HJ Wearing, HTH Nguyen, HW Hethcote, I. Z. Kiss, J Ma, JC Miller, JM Hyman, JP Koplan, K Sharkey, K. B. Blyuss, KB Blyuss, KTD Eames, KTD Eames, L Danon, M Newman, M Newman, M Taylor, MEJ Newman, MI Meltzer, MJ Keeling, MJ Keeling, MJ Keeling, MJ Keeling, MJ Keeling, N MacDonald, N. Sherborne, NM Ferguson, NM Ferguson, NTJ Bailey, O Diekmann, O Diekmann, P Driessche van den, P Rattana, R Durrett, RE Hope-Simpson, RM Anderson, S Bansal, S Boccaletti, S Cauchemez, S Funk, S Riley, T House, T House, T House, TL Burr, V Andreasen, W Kermack, W-Y Chen, Z Feng   +59 more
core   +2 more sources

The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing

Mediators of Inflammation, 2023
Background/Aims. The underlying mechanisms of differential responsiveness to IFN remain poorly understood. The elongation factor Tu GTP binding domain-containing protein 2 (EFTUD2), involved in RNA splicing and pre-mRNA processing, was recognized as a ...
Pingping Hu, Yuwen Li, Wen Zhang, Rui Liu, Linya Peng, Ruirui Xu, Jinyuan Cai, Hui Yuan, Tiantong Feng, Anran Tian, Ming Yue, Jun Li, Wenting Li, Chuanlong Zhu   +13 more
doaj   +1 more source

Anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: Potential clinical value [PDF]

, 2002
Anti-Saccharomyces cerevisiae antibodies (ASCA) have been described as specific markers in Crohn's disease and their healthy first-degree relatives. 171 patients with Crohn's disease, their 105 first-degree relatives, 145 patients with ulcerative colitis
Folwaczny, Christian, Glas, J., Herbinger, K. H., Hoelscher, Michael, Török, H.-P., Vilsmaier, F.   +5 more
core   +1 more source

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Clinical Infectious Diseases, 2008
BACKGROUND Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies.
B. D. de Pauw, Thomas J. Walsh, J. P. Donnelly, David A. Stevens, John E. Edwards, T. Calandra, Peter G Pappas, J. Maertens, O. Lortholary, Carol A. Kauffman, D. W. Denning, Thomas F. Patterson, G. Maschmeyer, J. Billé, W. Dismukes, R. Herbrecht, William W. Hope, C. Kibbler, B. Kullberg, K. Marr, P. Muñoz, F. Odds, J. Perfect, Á. Restrepo, M. Ruhnke, B. Segal, Jack D. Sobel, Tania C. Sorrell, C. Viscoli, J. Wingard, T. Zaoutis, John E. Bennett   +31 more
semanticscholar   +1 more source

Recovery of viral RNA and infectious foot-and-mouth disease virus from positive lateral-flow devices [PDF]

, 2014
Foot-and-mouth disease Virus (FMDV) is an economically important, highly contagious picornavirus that affects both wild and domesticated cloven hooved animals. In developing countries, the effective laboratory diagnosis of foot-and-mouth disease (FMD) is
Armson, Bryony, Bankowski, Bartlomiej M., Barnett, Paul V., Di Nardo, Antonello, Ferris, Nigel P., Fowler, Veronica L., King, Donald P., Mioulet, Valerie, Reid, Scott M., Valdazo-Gonzalez, Begoña, Wadsworth, Jemma   +10 more
core   +7 more sources

INFECTIOUS DISEASES. [PDF]

JAMA: The Journal of the American Medical Association, 1901
n ...
openaire   +3 more sources

Screening for Latent Tuberculosis Infection using Interferon-Gamma Release Assay Test among Healthcare Workers

Global Medical & Health Communication, 2023
Healthcare workers (HCWs) represent a significant demographic for screening latent tuberculosis infection (LTBI) due to their potential exposure to infectious patients.
Rosamarlina Rosamarlina, Nina Mariana, Titi Sundari, Tri Yuli Setianingsih, Jahiroh Jahiroh, Intan Pertiwi, Aninda Dinar Widiantari, Vivi Setiawaty, Farida Murtiani   +8 more
doaj   +1 more source

Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response

Frontiers in Immunology, 2019
The world has developed an elaborate global health system as a bulwark against known and unknown infectious disease threats. The system consists of various formal and informal networks of organizations that serve different stakeholders; have varying ...
D. Bloom, D. Cadarette
semanticscholar   +1 more source

Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening

Scientific Reports, 2022
We performed a high-throughput phenotypic whole cell screen of Mycobacterium tuberculosis against a diverse chemical library of approximately 100,000 compounds from the AbbVie corporate collection and identified 24 chemotypes with anti-tubercular ...
Anuradha Kumar, Somsundaram Chettiar, Brian S. Brown, Julie Early, Juliane Ollinger, Megan Files, Mai A. Bailey, Aaron Korkegian, Devon Dennison, Matthew McNeil, James Metz, Augustine Osuma, Michael Curtin, Aaron Kunzer, Gail Freiberg, Milan Bruncko, Dale Kempf, Tanya Parish   +17 more
doaj   +1 more source

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Clinical Infectious Diseases, 2022
Background There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence from trials.
A. Bhimraj, R. Morgan, A. Shumaker, L. Baden, V. Cheng, K. Edwards, Jason C. Gallagher, R. Gandhi, W. Muller, Mari M. Nakamura, J. O’Horo, R. Shafer, S. Shoham, M. H. Murad, R. Mustafa, S. Sultan, Y. Falck-Ytter   +16 more
semanticscholar   +1 more source